and Aims: Chronic obstructive pulmonary disease (COPD) is characterized by lung inflammation. Air pollution is strongly related to chronic obstructive pulmonary disease (COPD). Vanadium (V) is major transition metal often adhered to particulate matter and emitted into the atmosphere as vanadium pentoxide (V 2 O 5 ) by the combustion of fossil fuels and metallurgic industry activities. Particulate matter (PM) air pollution contributes to inflammation-related processes including COPD. Our aim is to evaluate the effect of vanadium on the inflammatory response in vitro and in patients with COPD.
Background and Aims: Chronic obstructive pulmonary disease (COPD) is characterized by lung inflammation. Air pollution is strongly related to chronic obstructive pulmonary disease (COPD). Vanadium (V) is major transition metal often adhered to particulate matter and emitted into the atmosphere as vanadium pentoxide (V 2 O 5 ) by the combustion of fossil fuels and metallurgic industry activities. Particulate matter (PM) air pollution contributes to inflammation-related processes including COPD. Our aim is to evaluate the effect of vanadium on the inflammatory response in vitro and in patients with COPD.
Methods:
The expression of proinflammatory cytokine and chemokine mRNA analyzed by real-time PCR. Reactive oxygen species (ROS) level determined by flow cytometry using DCF-DA staining. Cytometric beadbased assays were used to quantify inflammatory cytokines in the culture media and the plasma of healthy and COPD subjects. p-ERK and p-JNK expression were performed by western blot. Statistical analyses were performed using unpaired t-test at P < 0.05 with GraphPad Prism version. Conclusion: Our finding demonstrate that inflammatory response in patient with COPD is associated with vanadium, a usually component of particulate matter. And V 2 O 5 induce excessive inflammation through activating MAPK mediated oxidative stress signalling in BEAS-2B human bronchial epithelial cell. These evidence show that vanadium and its oxidant may contribute to chronic inflammation in patient with COPD. Background and Aims: Genetic variants for gene SERPINC1 has been shown to be associated antithrombin III deficiency, which subsequently contributed to the susceptibility to venous thrombosis. However, several studies showed the conflicting results regarding the association of SERPINC1 gene polymorphisms (rs2227589) with risk of thrombosis. The present study conducted a case-control study to further evaluate the association of the variant rs2227589 with antithrombin III deficiency and pulmonary embolism (PTE) risk in a Chinese population that has not been studied yet.
Methods: A case control study was performed on 101 patients and 199 healthy control. The allele frequency of SERPINC1 variant rs2227589 was analyzed by Sequenom assay. Active antithrombin III level was detected by an automatic coagulation analyser. A meta-analysis including 9 cohorts with 5419 venous thromboembolism (VTE) affected individuals and 8836 control subjects was performed.
Results: Total 27(26.7%) subjects were diagnosed with antithrombin III deficiency. Our results showed that antithrombin III plasma activities are slightly lower in the T allele carriers than that in C allele carriers, though it is not statistically significant. There was no significant correlation between rs2227589 genotype and antithrombin III plasma level. The recessive model showed that rs2227589 was significantly associated (P = 0.026) with an increased risk [OR:2.31, 95%CI (1.09-4.89)] of PTE. The meta-analysis showed that rs2227589 polymorphism was associated with an increased risk of VTE in the additive model [OR:1.10, 95% CI (1.02-1.20), P = 0.01] but not in the recessive model.
Conclusion:
Our study demonstrated that variant rs2227589 is associated with increased risk of PTE in Chinese population but didn't showed any correlation with antithrombin III plasma level. Meta-analysis showed significant association between rs2227589 and VTE risk in the additive genetic model. Methods: Seventy-seven children were evaluated (median age 9. AE .2 years). Sixty-six children had lung malformations (83%), eleven of them (17%) had ILD as an outcome of chronic/acute lung diseases.
Δψm was assessed by using flow cytometry analysis of cells stained with 5,5 0 ,6,6 0 -tetrachloro-1,1 0 ,3,3 0 -tetraethylbenzimidazole-carbocyanide iodine (JC-1, MitoScreen kit; BD Biosciences).
Results: Analyzing the Δψm parameters it was revealed that children with ILD had 1.7 times more lymphocytes with decreased Δψm than in control group (52.5 AE .15% и 31.1 AE .08% respectively, P < 0.001). 
